Follow
Robert S. Kerbel
Robert S. Kerbel
Sunnybrook Research Institute
Verified email at sri.utoronto.ca
Title
Cited by
Cited by
Year
Angiogenesis as a therapeutic target
N Ferrara, RS Kerbel
Nature 438 (7070), 967-974, 2005
34422005
Tumor angiogenesis
RS Kerbel
New England Journal of Medicine 358 (19), 2039-2049, 2008
29752008
Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis
JML Ebos, CR Lee, W Cruz-Munoz, GA Bjarnason, JG Christensen, ...
Cancer cell 15 (3), 232-239, 2009
21562009
Clinical translation of angiogenesis inhibitors
R Kerbel, J Folkman
Nature Reviews Cancer 2 (10), 727-739, 2002
21412002
The anti-angiogenic basis of metronomic chemotherapy
RS Kerbel, BA Kamen
Nature Reviews Cancer 4 (6), 423-436, 2004
17012004
Tumor angiogenesis: past, present and the near future
RS Kerbel
Carcinogenesis 21 (3), 505-515, 2000
15952000
Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity
G Klement, S Baruchel, J Rak, S Man, K Clark, DJ Hicklin, P Bohlen, ...
The Journal of clinical investigation 105 (8), R15-R24, 2000
15262000
β1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis
JW Dennis, S Laferté, C Waghorne, ML Breitman, RS Kerbel
Science 236 (4801), 582-585, 1987
12171987
Establishment and characterization of first trimester human trophoblast cells with extended lifespan
CH Graham, TS Hawley, RC Hawley, JR MacDougall, RS Kerbel, N Khoo, ...
Experimental cell research 206 (2), 204-211, 1993
11491993
Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in …
AM Petit, J Rak, MC Hung, P Rockwell, N Goldstein, B Fendly, RS Kerbel
The American journal of pathology 151 (6), 1523, 1997
11461997
Mutant ras Oncogenes Upregulate VEGF/VPF Expression: Implications for Induction and Inhibition of Tumor Angiogenesis
J Rak, Y Mitsuhashi, L Bayko, J Filmus, S Shirasawa, T Sasazuki, ...
Cancer research 55 (20), 4575-4580, 1995
10741995
Antiangiogenic therapy in oncology: current status and future directions
GC Jayson, R Kerbel, LM Ellis, AL Harris
The Lancet 388 (10043), 518-529, 2016
8822016
Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR
K Al-Nedawi, B Meehan, RS Kerbel, AC Allison, J Rak
Proceedings of the National Academy of Sciences 106 (10), 3794-3799, 2009
8192009
Antiangiogenic therapy: impact on invasion, disease progression, and metastasis
JML Ebos, RS Kerbel
Nature reviews Clinical oncology 8 (4), 210-221, 2011
8112011
The multifaceted circulating endothelial cell in cancer: towards marker and target identification
F Bertolini, Y Shaked, P Mancuso, RS Kerbel
Nature Reviews Cancer 6 (11), 835-845, 2006
7362006
Acquired resistance to the antitumor effect of epidermal growth factor receptor-blocking antibodies in vivo: a role for altered tumor angiogenesis
A Viloria-Petit, T Crombet, S Jothy, D Hicklin, P Bohlen, JM Schlaeppi, ...
Cancer research 61 (13), 5090-5101, 2001
7012001
Therapy-induced acute recruitment of circulating endothelial progenitor cells to tumors
Y Shaked, A Ciarrocchi, M Franco, CR Lee, S Man, AM Cheung, ...
Science 313 (5794), 1785-1787, 2006
6912006
A role for survivin in chemoresistance of endothelial cells mediated by VEGF
J Tran, Z Master, JL Yu, J Rak, DJ Dumont, RS Kerbel
Proceedings of the National Academy of Sciences 99 (7), 4349-4354, 2002
6622002
Consensus guidelines for the use and interpretation of angiogenesis assays
P Nowak-Sliwinska, K Alitalo, E Allen, A Anisimov, AC Aplin, R Auerbach, ...
Angiogenesis 21, 425-532, 2018
6372018
Maximum tolerable dose and low-dose metronomic chemotherapy have opposite effects on the mobilization and viability of circulating endothelial progenitor cells
F Bertolini, S Paul, P Mancuso, S Monestiroli, A Gobbi, Y Shaked, ...
Cancer research 63 (15), 4342-4346, 2003
6302003
The system can't perform the operation now. Try again later.
Articles 1–20